▶ 調査レポート

肝性脳症薬のグローバル市場調査 2019年
QYResearchが調査・発行した産業分析レポートです。肝性脳症薬のグローバル市場調査 2019年 / / QYR9NV05976資料のイメージです。• レポートコード：QYR9NV05976
• 出版社/出版日：QYResearch / 2019年11月12日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、101ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア
• 販売価格（消費税別）
  Single User￥525,000 (USD3,500)▷ お問い合わせ
  Enterprise License￥1,050,000 (USD7,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※本調査レポートは、肝性脳症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、RBX-2660、KLS-13019、GR-3027、SYNB-1020、その他に、用途別には、クリニック、病院、その他にセグメント区分し、肝性脳症薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・肝性脳症薬の世界市場概要
・肝性脳症薬の製造コスト構成分析
・肝性脳症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・肝性脳症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・肝性脳症薬のセグメント分析（種類別）
（RBX-2660、KLS-13019、GR-3027、SYNB-1020、その他）
・肝性脳症薬のセグメント分析（用途別）
（クリニック、病院、その他）
・肝性脳症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Alfa Wassermann S.p.A、Cosmo Pharmaceuticals S.p.A、Horizon Pharma Plc、KannaLife Sciences, Inc.、Ocera Therapeutics, Inc.、Rebiotix Inc.、Spherium Biomed S.L.、Umecrine Cognition AB、）
・肝性脳症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Hepatic Encephalopathy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hepatic Encephalopathy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hepatic Encephalopathy Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hepatic Encephalopathy Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hepatic Encephalopathy Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Alfa Wassermann S.p.A
Cosmo Pharmaceuticals S.p.A
Horizon Pharma Plc
KannaLife Sciences, Inc.
Ocera Therapeutics, Inc.
Rebiotix Inc.
Spherium Biomed S.L.
Umecrine Cognition AB

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
RBX-2660
KLS-13019
GR-3027
SYNB-1020
Others

Segment by Application
Clinic
Hospital
Others

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Hepatic Encephalopathy Drug
1.1 Definition of Hepatic Encephalopathy Drug
1.2 Hepatic Encephalopathy Drug Segment by Type
1.2.1 Global Hepatic Encephalopathy Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 RBX-2660
1.2.3 KLS-13019
1.2.4 GR-3027
1.2.5 SYNB-1020
1.2.6 Others
1.3 Hepatic Encephalopathy Drug Segment by Applications
1.3.1 Global Hepatic Encephalopathy Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Hepatic Encephalopathy Drug Overall Market
1.4.1 Global Hepatic Encephalopathy Drug Revenue (2014-2025)
1.4.2 Global Hepatic Encephalopathy Drug Production (2014-2025)
1.4.3 North America Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.4 Europe Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.5 China Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.6 Japan Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.8 India Hepatic Encephalopathy Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Drug
2.3 Manufacturing Process Analysis of Hepatic Encephalopathy Drug
2.4 Industry Chain Structure of Hepatic Encephalopathy Drug

3 Development and Manufacturing Plants Analysis of Hepatic Encephalopathy Drug
3.1 Capacity and Commercial Production Date
3.2 Global Hepatic Encephalopathy Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hepatic Encephalopathy Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hepatic Encephalopathy Drug Production and Capacity Analysis
4.2 Hepatic Encephalopathy Drug Revenue Analysis
4.3 Hepatic Encephalopathy Drug Price Analysis
4.4 Market Concentration Degree

5 Hepatic Encephalopathy Drug Regional Market Analysis
5.1 Hepatic Encephalopathy Drug Production by Regions
5.1.1 Global Hepatic Encephalopathy Drug Production by Regions
5.1.2 Global Hepatic Encephalopathy Drug Revenue by Regions
5.2 Hepatic Encephalopathy Drug Consumption by Regions
5.3 North America Hepatic Encephalopathy Drug Market Analysis
5.3.1 North America Hepatic Encephalopathy Drug Production
5.3.2 North America Hepatic Encephalopathy Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hepatic Encephalopathy Drug Import and Export
5.4 Europe Hepatic Encephalopathy Drug Market Analysis
5.4.1 Europe Hepatic Encephalopathy Drug Production
5.4.2 Europe Hepatic Encephalopathy Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hepatic Encephalopathy Drug Import and Export
5.5 China Hepatic Encephalopathy Drug Market Analysis
5.5.1 China Hepatic Encephalopathy Drug Production
5.5.2 China Hepatic Encephalopathy Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hepatic Encephalopathy Drug Import and Export
5.6 Japan Hepatic Encephalopathy Drug Market Analysis
5.6.1 Japan Hepatic Encephalopathy Drug Production
5.6.2 Japan Hepatic Encephalopathy Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hepatic Encephalopathy Drug Import and Export
5.7 Southeast Asia Hepatic Encephalopathy Drug Market Analysis
5.7.1 Southeast Asia Hepatic Encephalopathy Drug Production
5.7.2 Southeast Asia Hepatic Encephalopathy Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hepatic Encephalopathy Drug Import and Export
5.8 India Hepatic Encephalopathy Drug Market Analysis
5.8.1 India Hepatic Encephalopathy Drug Production
5.8.2 India Hepatic Encephalopathy Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hepatic Encephalopathy Drug Import and Export

6 Hepatic Encephalopathy Drug Segment Market Analysis (by Type)
6.1 Global Hepatic Encephalopathy Drug Production by Type
6.2 Global Hepatic Encephalopathy Drug Revenue by Type
6.3 Hepatic Encephalopathy Drug Price by Type

7 Hepatic Encephalopathy Drug Segment Market Analysis (by Application)
7.1 Global Hepatic Encephalopathy Drug Consumption by Application
7.2 Global Hepatic Encephalopathy Drug Consumption Market Share by Application (2014-2019)

8 Hepatic Encephalopathy Drug Major Manufacturers Analysis
8.1 Alfa Wassermann S.p.A
8.1.1 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Sites and Area Served
8.1.2 Alfa Wassermann S.p.A Product Introduction, Application and Specification
8.1.3 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Cosmo Pharmaceuticals S.p.A
8.2.1 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Sites and Area Served
8.2.2 Cosmo Pharmaceuticals S.p.A Product Introduction, Application and Specification
8.2.3 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Horizon Pharma Plc
8.3.1 Horizon Pharma Plc Hepatic Encephalopathy Drug Production Sites and Area Served
8.3.2 Horizon Pharma Plc Product Introduction, Application and Specification
8.3.3 Horizon Pharma Plc Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 KannaLife Sciences, Inc.
8.4.1 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
8.4.2 KannaLife Sciences, Inc. Product Introduction, Application and Specification
8.4.3 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Ocera Therapeutics, Inc.
8.5.1 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
8.5.2 Ocera Therapeutics, Inc. Product Introduction, Application and Specification
8.5.3 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Rebiotix Inc.
8.6.1 Rebiotix Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
8.6.2 Rebiotix Inc. Product Introduction, Application and Specification
8.6.3 Rebiotix Inc. Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Spherium Biomed S.L.
8.7.1 Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Sites and Area Served
8.7.2 Spherium Biomed S.L. Product Introduction, Application and Specification
8.7.3 Spherium Biomed S.L. Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Umecrine Cognition AB
8.8.1 Umecrine Cognition AB Hepatic Encephalopathy Drug Production Sites and Area Served
8.8.2 Umecrine Cognition AB Product Introduction, Application and Specification
8.8.3 Umecrine Cognition AB Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Hepatic Encephalopathy Drug Market
9.1 Global Hepatic Encephalopathy Drug Market Trend Analysis
9.1.1 Global Hepatic Encephalopathy Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Hepatic Encephalopathy Drug Regional Market Trend
9.2.1 North America Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.2 Europe Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.3 China Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.4 Japan Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.5 Southeast Asia Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.6 India Hepatic Encephalopathy Drug Forecast 2019-2025
9.3 Hepatic Encephalopathy Drug Market Trend (Product Type)
9.4 Hepatic Encephalopathy Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hepatic Encephalopathy Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Hepatic Encephalopathy Drug
Table Global Hepatic Encephalopathy Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Hepatic Encephalopathy Drug Production Market Share by Types in 2018
Figure RBX-2660 Product Picture
Figure KLS-13019 Product Picture
Figure GR-3027 Product Picture
Figure SYNB-1020 Product Picture
Figure Others Product Picture
Table Global Hepatic Encephalopathy Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Hepatic Encephalopathy Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) (2014-2025)
Figure Global Hepatic Encephalopathy Drug Production (K Pcs) (2014-2025)
Figure North America Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure Europe Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure China Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure Japan Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure India Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Table Hepatic Encephalopathy Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Drug in 2018
Figure Manufacturing Process Analysis of Hepatic Encephalopathy Drug
Figure Industry Chain Structure of Hepatic Encephalopathy Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hepatic Encephalopathy Drug Manufacturing Plants Distribution
Table Hepatic Encephalopathy Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hepatic Encephalopathy Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Hepatic Encephalopathy Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Hepatic Encephalopathy Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Hepatic Encephalopathy Drug Production Share by Manufacturers in 2018
Table Hepatic Encephalopathy Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hepatic Encephalopathy Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hepatic Encephalopathy Drug Revenue Share by Manufacturers in 2018
Table Hepatic Encephalopathy Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hepatic Encephalopathy Drug Production by Regions 2014-2019 (K Pcs)
Table Global Hepatic Encephalopathy Drug Production Market Share by Regions 2014-2019
Figure Global Hepatic Encephalopathy Drug Production Market Share by Regions in 2018
Table Global Hepatic Encephalopathy Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Hepatic Encephalopathy Drug Revenue Market Share by Regions 2014-2019
Figure Global Hepatic Encephalopathy Drug Revenue Market Share by Regions in 2018
Table Global Hepatic Encephalopathy Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Hepatic Encephalopathy Drug Consumption Market Share by Regions 2014-2019
Figure North America Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure China Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure India Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Hepatic Encephalopathy Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hepatic Encephalopathy Drug Market Share by Application (2014-2019)
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Sites and Area Served
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Main Business and Markets Served
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Sites and Area Served
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Main Business and Markets Served
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Production Sites and Area Served
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Main Business and Markets Served
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Main Business and Markets Served
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Main Business and Markets Served
Table Rebiotix Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
Table Rebiotix Inc. Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Rebiotix Inc. Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Rebiotix Inc. Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Rebiotix Inc. Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Rebiotix Inc. Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Rebiotix Inc. Hepatic Encephalopathy Drug Main Business and Markets Served
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Sites and Area Served
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Main Business and Markets Served
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Production Sites and Area Served
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Main Business and Markets Served
Figure Global Hepatic Encephalopathy Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hepatic Encephalopathy Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Hepatic Encephalopathy Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Hepatic Encephalopathy Drug by Application (2019-2025)
Table Hepatic Encephalopathy Drug Distributors List
Table Hepatic Encephalopathy Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 甲状腺機能低下症薬のグローバル市場調査 2019年
    Global Hypothyroidism Drug Market Professional Survey Report 2019
    QYR9NV06525 2019年11月12日 109Pages
    ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、...
  • コクシジオイデス症薬剤のグローバル市場調査 2019年
    Global Coccidioidomycosis Drug Market Professional Survey Report 2019
    QYR9NV02704 2019年11月12日 105Pages
    ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、そ...
  • ファンコニ貧血薬のグローバル市場調査 2019年
    Global Fanconi Anemia Drug Market Professional Survey Report 2019
    QYR9NV04652 2019年11月12日 109Pages
    ※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途...
  • 退形成性乏突起膠腫薬のグローバル市場調査 2019年
    Global Anaplastic Oligoastrocytoma Drug Market Professional Survey Report 2019
    QYR9NV00713 2019年11月12日 106Pages
    ※本調査レポートは、退形成性乏突起膠腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CDX-1401、デパツキシズマブマフォドチン、フルシトシン、その他に...
  • 色素性絨毛結節性滑膜炎薬のグローバル市場調査 2019年
    Global Pigmented Villonodular Synovitis Drug Market Professional Survey Report 2019
    QYR9NV09935 2019年11月14日 101Pages
    ※本調査レポートは、色素性絨毛結節性滑膜炎薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カビラリズマブ、エマツズマブ、Mcs-110、ニロチニブ、その他に...
  • 膿痂疹薬のグローバル市場調査 2019年
    Global Impetigo Drug Market Professional Survey Report 2019
    QYR9NV06572 2019年11月12日 106Pages
    ※本調査レポートは、膿痂疹薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、FMX-102、LTX-109、ムピロシン、オゼノキサシン、その他に、用途別には、...
  • ヘテロ接合性家族性高コレステロール血症薬のグローバル市場調査 2019年
    Global Heterozygous Familial Hypercholesterolemia Drug Market Professional Survey Report 2019
    QYR9NV06000 2019年11月12日 109Pages
    ※本調査レポートは、ヘテロ接合性家族性高コレステロール血症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ゲムカベンカルシウム、MGL-3196、ST-10...
  • 緑膿菌肺炎治療薬のグローバル市場調査 2019年
    Global Pseudomonas Aeruginosa Pneumonia Drug Market Professional Survey Report 2019
    QYR9NV10765 2019年11月14日 107Pages
    ※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途...
  • 胃腸運動障害薬のグローバル市場調査 2019年
    Global Gastric Motility Disorder Drug Market Professional Survey Report 2019
    QYR9NV05413 2019年11月12日 102Pages
    ※本調査レポートは、胃腸運動障害薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ベルセトラグ、イパモレリン、TD-8954、その他に、用途別には、病院、診療...
  • 併用療法薬のグローバル市場調査 2019年
    Global Combination Therapy Drug Market Professional Survey Report 2019
    QYR9NV02770 2019年11月12日 104Pages
    ※本調査レポートは、併用療法薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グリチルリチン酸二アンモニウム、インターフェロンおよびヌクレオシド薬、標的療法薬...
  • 甲状腺機能低下症薬のグローバル市場調査 2019年甲状腺機能低下症薬のグローバル市場調査 2019年 The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this…
  • コクシジオイデス症薬剤のグローバル市場調査 2019年コクシジオイデス症薬剤のグローバル市場調査 2019年 The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspecti…
  • ファンコニ貧血薬のグローバル市場調査 2019年ファンコニ貧血薬のグローバル市場調査 2019年 The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this…
  • 世界及び中国の薬物送達市場2018世界及び中国の薬物送達市場2018 The 'Global and Chinese Drug Discovery Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Drug Discovery industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drug Discovery manufac…
  • 世界及び中国の耳鳴り治療薬市場2018世界及び中国の耳鳴り治療薬市場2018 The 'Global and Chinese Tinnitus Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Tinnitus Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tinnitus Drug manufactur…